Header Ads

Rival drugmakers launch joint trial of medicines for COVID-19

August 03, 2020
Rival drugmakers AbbVie Inc, Amgen Inc and Takeda Pharmaceuticals Inc on Monday said they have begun treating patients in a trial to quickly show whether a drug from each company can be repurposed and used against COVID-19, the disease caused by the novel coronavirus. Read More

from Canoe https://ift.tt/33hMSi5

Post a Comment

No comments

Subscribe to: Post Comments ( Atom )